CA Stock MarketDetailed Quotes
HBP Helix BioPharma Corp
- 0.225
- 0.0000.00%
15min DelayPost Market Jul 26 16:00 ET
55.15MMarket Cap-5769P/E (TTM)
0.000High0.000Low0Volume0.000Open0.225Pre Close0.00Turnover0.27052wk High0.00%Turnover Ratio245.11MShares0.15052wk Low-0.039EPS TTM46.32MFloat Cap8.050Historical HighLossP/E (Static)205.89MShs Float0.060Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM-112.50P/B1Lot Size--Div YieldTTM
Helix BioPharma Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 25.13%-1.13M | -39.01%-1.52M | -31.42%-1.83M | 15.07%-5.53M | 15.29%-1.54M | 7.10%-1.5M | 20.64%-1.09M | 17.94%-1.39M | 24.99%-6.51M | 13.96%-1.82M |
| Net income from continuing operations | -36.06%-1.83M | 23.88%-902K | 21.92%-1.25M | 4.16%-6.29M | -55.41%-2.15M | 0.00%-1.35M | 41.31%-1.19M | 11.42%-1.61M | 18.35%-6.56M | 49.96%-1.39M |
| Operating gains losses | 172.73%8K | --5K | -53.85%12K | -155.56%-5K | -42.86%-20K | ---11K | --0 | 966.67%26K | 100.57%9K | -148.28%-14K |
| Depreciation and amortization | 33.33%4K | 0.00%3K | 33.33%4K | 8.33%13K | 33.33%4K | 0.00%3K | 0.00%3K | 0.00%3K | -93.97%12K | -95.16%3K |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 252.82%501K | -97.18%4K |
| Remuneration paid in stock | -82.35%6K | -82.93%21K | 112.50%34K | 33.88%569K | 1,031.43%396K | -57.50%34K | -49.80%123K | -75.38%16K | -35.90%425K | -12.50%35K |
| Other non cashItems | ---- | ---- | -2,500.00%-24K | ---- | ---- | ---- | ---- | --1K | ---1K | ---- |
| Change In working capital | 470.81%686K | -1,854.55%-645K | -467.06%-624K | 120.85%186K | 150.87%234K | 72.75%-185K | -110.61%-33K | 365.63%170K | -1,551.85%-892K | -219.79%-460K |
| -Change in receivables | -212.50%-25K | 0.00%6K | -104.17%-7K | 193.24%217K | -27.14%51K | 73.33%-8K | 160.00%6K | 281.82%168K | 142.77%74K | 79.49%70K |
| -Change in prepaid assets | -256.56%-191K | -15.38%22K | 80.22%-18K | 157.81%37K | 79.59%-20K | 165.22%122K | 204.00%26K | -800.00%-91K | -540.00%-64K | -155.06%-98K |
| -Change in payables and accrued expense | 369.62%852K | -4,907.14%-673K | 329.03%399K | 92.46%-68K | 132.64%141K | 54.53%-316K | -95.95%14K | 176.86%93K | -799.22%-902K | -358.68%-432K |
| -Change in other current liabilities | 194.12%50K | --0 | ---998K | ---- | ---- | --17K | ---79K | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 25.20%-1.13M | -36.69%-1.49M | -33.24%-1.85M | 15.09%-5.53M | 15.34%-1.54M | 7.10%-1.5M | 20.57%-1.09M | 17.99%-1.39M | 30.04%-6.51M | -2.48%-1.82M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -100.00%-12K | -5K | 4K | 0 | -3K | -6K | 0 | 0 |
| Net PPE purchase and sale | --0 | --0 | -100.00%-12K | ---5K | --4K | --0 | ---3K | ---6K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | -100.00%-12K | ---5K | --4K | --0 | ---3K | ---6K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.72M | 100.21%1K | 4.64%2.69M | -50.25%3.09M | -68.57%998K | 0 | -478K | 2.57M | -5.44%6.21M | 2.32%3.18M |
| Net issuance payments of debt | --0 | --0 | --0 | ---2.06M | --406K | --0 | --0 | ---2.47M | --0 | --0 |
| Net common stock issuance | --1.72M | -99.98%1K | 561.58%2.69M | 38.64%4.15M | -4,411.11%-406K | --0 | --4.15M | --406K | -15.92%2.99M | ---9K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --3.21M | --3.18M |
| Net other financing activities | ---- | ---- | ---- | --999K | ---- | ---- | ---- | --4.63M | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --1.72M | 100.21%1K | 4.64%2.69M | -50.23%3.09M | -68.54%999K | --0 | ---478K | --2.57M | -5.44%6.21M | 2.32%3.18M |
| Net cash flow | ||||||||||
| Beginning cash position | -95.75%120K | -62.68%1.64M | -75.15%808K | -8.78%3.25M | -29.33%1.33M | 499.36%2.82M | 134.76%4.4M | -8.78%3.25M | -15.82%3.57M | -16.95%1.88M |
| Current changes in cash | 139.76%598K | 3.68%-1.52M | -27.84%845K | -703.95%-2.44M | -139.60%-537K | -206.59%-1.5M | -14.39%-1.57M | 169.09%1.17M | 57.89%-304K | 2.11%1.36M |
| Effect of exchange rate changes | -172.73%-8K | ---5K | 53.85%-12K | --0 | 7.14%15K | --11K | --0 | -966.67%-26K | -117.31%-9K | 148.28%14K |
| End cash Position | -46.62%710K | -95.75%120K | -62.68%1.64M | -75.15%808K | -75.15%808K | -29.33%1.33M | 499.36%2.82M | 134.76%4.4M | -8.78%3.25M | -8.78%3.25M |
| Free cash from | 25.20%-1.13M | -36.31%-1.49M | -33.52%-1.86M | 14.93%-5.54M | 15.28%-1.54M | 7.10%-1.5M | 20.35%-1.1M | 17.64%-1.4M | 30.04%-6.51M | -2.48%-1.82M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg